Table 2 The difference of ZMIZ2 expression between different subtypes
From: ZMIZ2 promotes the development of triple-receptor negative breast cancer
Group | logFC | P value |
|---|---|---|
Cancer-Normal | 0.436174019 | 9.88E−17 |
TNBC-Normal | 0.786992 | 2.44E−32 |
HER2-Normal | 0.260674 | 0.00946 |
Lum-Normal | 0.371459 | 3.23E−13 |
Lum-TNBC | 0.415533 | 5.76E−17 |
Lum-HER2 | 0.110785 | 0.225652 |
TNBC-HER2 | 0.526317 | 1.54E−07 |
HER2 (POS-NEG) | − 0.19074 | 0.000279 |